ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Proteostasis Therapeutics, Inc." (PTI) Report Updated: Mar 18, 2017 | Print This Page

Get more stock ratings by Louis Navellier

"Proteostasis Therapeutics, Inc." (PTI)

Rating: Hold Volatility: Aggressive
Total Grade: C Industry: Biotechnology
Competitors: BCRX,CLCD,EXAS,GLPG

Stock Analysis

Rating: Monthly View

A
B
C
D
F
March April May June July August September October November December January February

Rating: Weekly View

This Week: C down downgrade
Last Week: B same no change
Two Weeks Ago: B up no change
service keys

"Proteostasis Therapeutics, Inc."© quotemedia

Company Profile